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Abstract 
A stretch of 28 ‘alternating’ lysine (K) and glutamate (E) residues is found in an activator of the multicatalytic protease. Such ‘KEKE sequences’ 
are also present in subunits of the multicatalytic protease, in subunits of the 26s protease and in a variety of chaperonins. We propose that KEKE 
regions promote association between protein complexes. Furthermore, they may contribute to the selection of peptides presented on MHC 
Class I receptors. 
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1. IlltToduction 
Two large proteases are found in the cytosolic and 
nuclear compartments of eukaryotic cells. One enzyme 
is known as the multicatalytic protease (MCP) or 20s 
proteasome [l-3]. MCP is composed of 24-28 subunits 
with a combined mass of about 650 kDa and it appears 
to be a hollow cylinder consisting of four stacked rings 
(see Fig. 1). MCP is the proteolytic core of an even larger 
enzyme, the 26s protease. In the presence of nucleotides, 
MCP cylinders associate with a regulatory ATPase com- 
plex (AC) that contains 15 or more polypeptides [4] rang- 
ing in molecular weight from 25 to 110 kDa (see Fig. 1). 
At least three ATPases [5] and a component that binds 
polymers of ubiquitin [6] are present among subunits of 
the regulatory complex. For certain substrates degrada- 
tion by the 26s protease requires prior attachment of Ub 
chains [7]. However, recent studies demonstrate that un- 
modified ornithine decarboxylase is degraded by the 26s 
enzyme [8]. 
MCP also associates with a protein hexamer [9,10] 
that we call the regulator (REG). Association of MCP 
and REG does not require nucleotides and does not 
convert MCP to a proteinase. REG binding does, how- 
ever, result in substantial activation of peptide hydroly- 
sis. We recently cloned and expressed an intact cDNA 
encoding the human REG subunit [I 11. Conceptual 
translation of the cDNA results in a protein 249 amino 
acids long. Near the center of the sequence, sandwiched 
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between two regions characteristic of globular domains, 
there are 28 ‘alternating’ lysine and glutamic acid resi- 
dues (see Fig. 2). We call this unusual feature of the 
protein’s sequence a ‘KEKE motif, and it prompted the 
hypotheses presented here. We propose that KEKE mo- 
tifs promote association between proteins. We further 
suggest that the regulator recognizes KEKE-like se- 
quences in cellular or viral proteins and directs adjacent 
regions for presentation on MHC Class I receptors. 
In reference 11, we defined KEKE motifs as greater 
than 12 amino acids in length, devoid of W, Y, F or P, 
more than 60% K and E/D, and lacking five positive or 
negatively charged residues in a row. KEKE motifs so 
defined are present in two 01 subunits of MCP, in subunit 
12 of the ATPase complex that forms the 26s protease 
and in a number of chaperonins (Fig. 2). Of the more 
than 100,000 entries in PIR Library (release 39), 106 
proteins were found to contain such KEKE motifs. 
Equivalent regions composed of arginine (R) and aspar- 
tate (D) are present in only two proteins, RD protein and 
hnRNP70 [12,13]. Considering all proteins in the data 
bank, the abundance of arginine is comparable to that 
of lysine; similarly aspartate and glutamate are present 
at equivalent frequency. Yet there are only two RDRD 
proteins and more than 100 KEKE proteins. Thus, 
KEKE motifs like those presented in Fig. 2 are not sim- 
ply statistically expected arrangements of amino acids. 
Our proposal that KEKE motifs promote pro- 
tein: protein association is based in part on their 
presence in four proteins known to bind each other. It 
is well documented that MCP associates both with AC 
and REG [4,9,10,14]. Each of these multisubunit com- 
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Fig. 1. Activation of the multicatalytic protease (proteasome). The 
multicatalytic protease is shown associating with two protein com- 
plexes, the ATPase complex (AC) and the regulator (REG), that acti- 
vate its peptidase activities. We propose that KEKE regions mediate 
such associations. 
plexes contains at least one component with a strong 
KEKE motif (Fig. 2). Since we have also found that 
MCP can form a stable complex with Hsp 90 (Hough 
and Rechsteiner, unpublished), four proteins with 
KEKE sequences bind to one another. Although such 
interactions may not involve the KEKE motifs per se, it 
seems reasonable to speculate that these regions are re- 
sponsible for the observed associations. In fact, two stud- 
ies have implicated KEKE motifs in protein-protein in- 
teraction. Nobel et al. [15] identify a KEKE region in 
MAP 1B as being responsible for its binding to microtu- 
bules. Likewise, Lu et al. [16] found that the interaction 
of dihydropyridine receptors with the calcium release 
channel involves KEKE regions. 
Preliminary experiments in our lab also provide direct 
evidence for KEKE-mediated association of proteins. 
Using the KEKE motif from REG, we have produced 
a ubiquitin KEKE fusion peptide, (Ub-PVKEKE- 
KEERKKQQEKEDKDEKKKGED). This chimera 
binds the REG whereas Ub does not; moreover, Ub- 
KEKE potentiates the activity of the REG (Realini and 
Rechsteiner, in preparation). We do not know whether 
binding results from direct KEKE: KEKE interactions 
or association between the KEKE motif and a KEKE- 
binding site. However, future experiments involving 
model peptides should resolve this issue. 
Our second hypothesis is an extension of the idea that 
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KEKE sequences promote protein association. We pro- 
pose that the regulator associates with KEKE-like se- 
quences in cellular proteins or proteins from pathogens. 
We envision that this association is transient and that it 
results in MCP-mediated cleavage of the cellular/patho- 
gen proteins. Like many others [17-191, we believe that 
the peptides generated by MCP are eventually trans- 
ported to the cell surface for presentation to lympho- 
cytes. Current views of antigen presentation by Class I 
receptors encoded in the major histocompatibility locus 
(MHC) invokes cytosolic proteolysis of cellular, viral or 
other parasitic proteins to produce peptides [ 17-191. 
These peptides are transported into the endoplasmic 
reticulum (ER) lumen where they bind a groove in the 
MHC I receptor that accommodates protein fragments 
8 to 10 amino acids in length. Association of the MHC 
I receptor with a tight-binding peptide and p2 microglob- 
ulin releases it from calnexin, an 88 kDa chaperonin 
embedded in the ER membrane. The MHC I : peptide :/$ 
microglobulin complex then travels to the cell surface. A 
number of questions concerning this pathway are unre- 
solved, and some are controversial. What cellular pro- 
tease(s) generates the peptides? How big are the peptides? 
How are they selected? Is peptide transport into the ER 
energy-dependent? Does peptide trimming occur in the 
ER?, etc. 
Our hypothesis, which focuses on how peptides might 
be selected from precursor proteins, resulted from in- 
spection of the JAK 1 kinase sequence [20]. Cells typi- 
cally display about 50,000 MHC I receptors on their 
surface. Most peptides bound to MHC I receptors are 
present at 10 to 100 copies per cell. However, there are 
10,000 copies of the peptide, SFFPEITHI, bound to 
MHC I receptors on ~815 cells [18]. SFFPEITHI, which 
originates from JAK 1 kinase, is found in the sequence 
KEKEKNKLKRKKLENKDKKDEEKNKIREEWNN 
F S F F P E I T H I. Given the proximity of such a highly 
presented peptide to a strong KEKE motif, we examined 
the sequence context of a large number of presented 
peptides (see Table 1). Inspection of these sequences re- 
vealed a high occurrence of KEKE-rich regions in pre- 
cursors to presented peptides. Ten of the 54 sequences 
(18.5%) in Table 1 contain KEKE regions, whereas only 
106 of the 100,346 entries in PIR LIB (release 39) contain 
REGULATOR . . . . KEKEKEERKKGPEKEOKOEKKKGEOEDK . . . . . . . . . . . . 
PROTEASOME C9 . . . . KKHEEEEAKAEREKKEKEQREKDK . . . . . . . . . . . . . . . . 
PROTEASOME 28.1.... KI IEKEKEEELEKKKGK . . . . . . . . . . . . . . . . . . . . . . . . 
28s SUBUNIT 12 . . . . EKKEGPEKEESKKDRKEDKEKDKOKEKSDVKKEEKK.. . 
CALNEXIN . . . . KEEEEEKEEEKDKGDEEEEGEEKLEEKPKSDAE . . . . . . . 
JAK 1 KINASE . . . . EKEKNKLKRKKLENKDKKDEEKNKIREE . . . . . . . . . . . . 
hHSP90 . . . . EEKEDKEEEKEKEEKESEDK . . . . . . . . . . . . . . . . . . . . . 
yHSP70 . . . . EKLAAGRKAEAEKKEEKKDTE . . . . . . . . . . . . . . . . . . . . 
Fig. 2. KEKE motifs in chaperonins, proteolytic components and a 
y-IFN activated protein kinase. KEKE regions from the sequences of 
selected proteins are presented in the one letter amino acid code. Pro- 
teins were included on the basis of their likely involvement in antigen 
presentation. 
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stringent KEKEs. We estimate that there is a 5- to lo- 
fold redundancy in PIR LIB so the frequency of KEKEs 
lies between 106 in 20,000 and 106 in 10,000 distinct 
proteins. At most, KEKE-plus proteins constitute 1% of 
the proteins in PIR LIB. Thus, there is at minimum a 
20-fold en~c~ent for strict KEKE motifs in proteins 
presently known to generate MHC I presented peptides. 
Another six proteins almost conform to our definition of 
a KEKE motif. Based on the sequences in Fig. 2 and 
Table 1, we developed two algorithms to identify KEKE 
111 
regions (KEKE Searches). One algo~t~ identifies all 
the proteins in Fig. 2, 7 of 52 precursors to MHC I 
presented peptides and 3.7% of the 33,329 entries in the 
SWISSPROT data bank (release 27). The other algo- 
rithm, which is less stringent, identifies 41% of the known 
precursors to MHC I presented peptides and 16% of the 
entries in SWISS.PROT. These and any newly developed 
algorithms will be available from the authors upon re- 
quest. 
The idea that KEKE motifs promote association can 
Table 1 
KEKE sequences in precursors to presented peptides 
[KIK~KNKLKRIKL~N~DIX~~~~~~IRE~] wNNF S F F P E I T Ii I JAXl 
[EELKKKMLLS~AK] FENLCKLMKEILDKKVEKVT HSP90 
[XKZKARVITXEXX~NFKAFASLRMARANAKLFGIKAK BBC1 
~zKLDIxLDsXDXDXLGX]PLLKAVMRRWLPAGDA eEFZ 
[XTLDNK1XXSAXD]ALLLWCQMKTAGYPNVNIKNF spectrin 
IXP~IXXDDLXXEXKDDLPX**XXD~LP _..  
XEtXXDDPPXEXXXDDLPX=XXXDAPXD 
G N X D a P X Z X X X A D P P X X]...(VaDPNAP),... EDSYVPSAEQILKPVKQW P. yoelii 
[~GKXNXKKNXXIZRNNX]-(p rorlch)-NNDDSYIPSAEKILEFVKQI P. berghel 
[K 1 G A D X B X X X x X G X I X X E JZ]-(GQAP),-N E K V V N D Y L L H K I R S S V T T P. knowlsei 
[XDTKKALDXIELXQNKSXXK]-(Q-rich)-RW I I L G L N K HIVgag 
[K E I C II X N D E C I s s X L]-(62)-N I R T L I Q I L K Q K I A D L IL6 precurs. 
R RIKEIV K K-(13)-[~XSRDXX"~DDEAEXBDXLB~XLXZEXLSEDX] HSP90 
A RL FG IRA[K RAXEAAEQDVBXKK] BBC1 
[R A 8 E E D X X E D]-(60)-E- N T V B D A K R L I G R BIP 
[XZZGXGXDASGNKVXAZ]-(341-~vNLP Q K AG 0 F L M PGK 
[XMXKRLsXFIXDaDELX]- 
(15,-[E X DA E L X XL R N El-(24)-K " K L E L K V K N L R L restin 
BY LB K IQNSLSTEWSPCSV T-[17)-[XDXLDYANDIXKXICXMEX] P. falc. 
Q G I N N L D 1 L-(-150)-[X D S Q II N AD X N ED G G X II T.Ag.polyom 
KYQAVTTTL-[EEKRKBKAIIHYRI T.A. P198 
SIIl?FBKL 
VSDIVGPDGLVY 
FAPGNYPAL 
GILGFVFTL 
XIEPRTLQY 
TQHNRALDL 
LLFGYPVYV 
PKYVKQNTLKLA 
TLWVDPYEV 
EADPTGBSYV 
LYQNVGTYV 
RRYPDAVYL 
HPKYKTEL 
EPKYKTQL 
ASNENYRTY 
SGPSNTPPEI 
STGNLIAPEYGFKIS 
RPQASGVYM 
IYATVAGS 
oval. 
fibrillarin 
Sendai 
Flu matrix 
riba. 516 
P91A 
HTLV-I 
Flu. Hem. p. 
TIS21 
MAG-1 ag 
Flu hemagglut. 
measles fUS. pxo. 
tristet. 
PPAS (yeast) 
Flu hemagglut. 
ElA 32 K 
Flu (A,JAP) 
LNC" N.P. 
Flu hemgglut. 
LSPFPFDL 
SSEQTFYYY 
RGYVYQGL 
BYLNKIQNSL- 
STEWSPCSVT 
RRSKRITVR 
GYKDGNEYI 
SSIEFARL 
VPKLKVCAL 
GILGFVFTL 
SAINNYAQKL 
CKGVNREYL 
TYQRTRALV 
GRAPVTIGK 
PRYNGLIRR 
GRIDKPIL 
RYLKNGKETL- 
QRA 
OGDH 
ODC (human) 
VsV NUC Prot 
P. falc. 
P68 
listeriol. 
herpes vir 
ribos. L18 
Flu matrix 
TAg polyoma 
TAq polyoma 
Fl" 
HIV-GP160 
rxbo. L28 
ribo. L8 
HLA CW-3 
Large letters denote sequences of presented peptides. The smaller letters are amino acid sequences flanking them. The sequences are taken mainly 
from Falk and RGtzschke [Z], Rammensee t al. [24, Jardetsky et al. 1271, Hunt et al. [28], Di Brino et al. (291, and Corr et al. [30]. 
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Fig. 3. Hypothetical KEKE-mediated association of regulator-MCP 
complex with calnexin. This diagram depicts our proposed mechanism 
for channeling peptides to the MHC I receptor. See text for a more 
complete description. 
account for their significant enrichment in components 
of the 26S/MCP proteolytic pathway and for their en- 
richment in proteins that are the source of presented 
peptides. As noted above, KEKE motifs could, like leuc- 
ine zippers, interact directly to mediate association. Al- 
ternatively, the REG may possess both KEKE sequences 
and KEKE binding sites. We consider both possibilities 
in the following discussion. The number of KEKE se- 
quences (or KEKE-binding sites) in each component of 
the presentation pathway suggests how the process might 
occur. Two subunits located in the end rings of MCP 
contain C-terminal KEKE extensions. Each identical 
subunit of the REG hexamer possesses a KEKE motif 
(or KEKE-binding site). Thus, one can imagine that the 
REG binds MCP with either KEKEs or KEKE-binding 
sites to spare. The excess elements in the regulator would 
be available to bind KEKE-like regions in potential pro- 
teolytic substrates. A 40 residue KEKE sequence is pres- 
ent in the cytoplasmic tail of calnexin. As mentioned 
above, this chaperonin holds MHC I receptors in the 
endoplasmic reticulum until immunogenic peptides bind 
them. Given these observations, one can arrive at a rea- 
sonably detailed hypothesis for how cells generate pep- 
tides and transfer them to the MHC I receptor. REG 
binds substrates and MCP facilitating their cleavage 
by MCP. REG can also bind calnexin either by direct 
KEKE: KEKE interaction or by virtue of KEKE- 
binding sites. This results in peptides being generated 
adjacent to the ER membrane. Released peptides are 
transferred into the ER lumen, presumably by TAPS 
(transporters associated with antigen processing). These 
ideas are diagrammed in Fig. 3 except that substrates 
have been omitted for clarity. 
By itself, REG does not enhance the cleavage of folded 
proteins, like lysozyme or bovine serum albumin [lo]. 
One might, therefore, question our proposal that REG 
promotes precursor cleavage by MCP. It should be 
noted, however, that REG does enhance degradation of 
casein, and it promotes the degradation of certain iodi- 
nated proteins (see Fig. 12, panel B versus C in ref. 10). 
Moreover, it is possible that REG binds substrates when 
they are nascent chains or that REG collaborates with 
heat shock proteins; e.g. hsp 70 or hsp 90, to promote 
substrate degradation by MCP. Thus, REG may select 
substrates directly or in concert with additional prote- 
olyticlchaperonin factors. 
To reiterate, the presence of six KEKE regions 
(KEKE-binding sites) in the assembled REG raises the 
possibility that it can simultaneously associate with 
MCP, substrates and calnexin. By doing so, we imagine 
that the REG channels available MCPs into the antigen 
processing pathway. In fact, we have recently demon- 
strated that y-IFN induces synthesis of the REG in 
HeLa cells [ 1 l] as has been observed for other postulated 
components of the antigen presentation pathway (e.g. 
TAPVTAP2, MHC-Class I and Class II receptors, as 
well as the LMP2 and LMP7 subunits of the multicata- 
lytic protease). 
In summary, we have found significant enrichment of 
lysine-glutamate tracts in cellular components thought 
to be involved in antigen presentation and in precursors 
to presented peptides. Our hypothesis that these KEKE 
motifs are involved in protein association is directly sup- 
ported by our studies with Ub-KEKE. However, it has 
not been demonstrated that KEKE regions are impor- 
tant for presentation of antigenic peptides. And we cer- 
tainly do not suggest hat all peptides presented on MHC 
I receptors are selected on the basis of KEKE regions. 
In fact, there is evidence that the 26s ATP/Ub-dependent 
protease can provide peptides for presentation by MHC 
I receptors [21,22]. It is interesting in this regard that 12 
of 35 KEKE negative precursors in Table 1 contain 
PEST sequences [23] which are known to promote rapid 
proteolysis. And the 26s enzyme has been shown to de- 
grade one PEST-plus protein, ornithine decarboxylase 
PI. 
We have not postulated a structural basis for KEKE- 
mediated interactions. In this regard, however, we note 
that a similar motif, . . .(EEEKKAAEERAKA),S . 
present in caldesmon, is likely to be a helix [24]. Accord- 
ingly, we suspect hat KEKEs form helices, and these, in 
turn, may form coiled-coils. Whatever the case, our hy- 
pothesis makes a number of readily testable predictions. 
And because the hypothesis has important implications 
for producing specific peptide: MHC I complexes, we 
believe it warrants experimental challenge. 
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